nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—CA2—osteoporosis	0.556	1	CbGaD
Sulpiride—CA12—Zoledronate—osteoporosis	0.224	0.553	CbGbCtD
Sulpiride—CA2—Zoledronate—osteoporosis	0.181	0.447	CbGbCtD
Sulpiride—CA2—Metabolism—ATIC—osteoporosis	0.000109	0.00284	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—GPX1—osteoporosis	0.000108	0.00281	CbGpPWpGaD
Sulpiride—BCHE—Peptide hormone metabolism—IGF1—osteoporosis	0.000107	0.00277	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ACP5—osteoporosis	0.000106	0.00277	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PKM—osteoporosis	0.000106	0.00276	CbGpPWpGaD
Sulpiride—CA9—Metabolism—FDPS—osteoporosis	0.000106	0.00276	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000103	0.00267	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GPD2—osteoporosis	0.000101	0.00262	CbGpPWpGaD
Sulpiride—CA12—Metabolism—IDH2—osteoporosis	0.000101	0.00262	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PGLS—osteoporosis	0.000101	0.00262	CbGpPWpGaD
Sulpiride—CA6—Metabolism—TPI1—osteoporosis	9.89e-05	0.00257	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—CNR2—osteoporosis	9.88e-05	0.00257	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.84e-05	0.00256	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.59e-05	0.00249	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYP27A1—osteoporosis	9.46e-05	0.00246	CbGpPWpGaD
Sulpiride—CA6—Metabolism—P4HB—osteoporosis	9.3e-05	0.00242	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—TUBA1B—osteoporosis	9.3e-05	0.00242	CbGpPWpGaD
Sulpiride—CA2—Metabolism—OXCT1—osteoporosis	9.28e-05	0.00241	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ATIC—osteoporosis	9.2e-05	0.00239	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PNP—osteoporosis	9.2e-05	0.00239	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ACP5—osteoporosis	9.2e-05	0.00239	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	9.17e-05	0.00238	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GAPDH—osteoporosis	9.13e-05	0.00237	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MGLL—osteoporosis	9.05e-05	0.00235	CbGpPWpGaD
Sulpiride—CA6—Metabolism—RAP1A—osteoporosis	8.89e-05	0.00231	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PTH1R—osteoporosis	8.63e-05	0.00224	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CALCR—osteoporosis	8.63e-05	0.00224	CbGpPWpGaD
Sulpiride—CA12—Metabolism—TPI1—osteoporosis	8.56e-05	0.00222	CbGpPWpGaD
Sulpiride—CA12—Metabolism—P4HB—osteoporosis	8.04e-05	0.00209	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—PTH—osteoporosis	8.02e-05	0.00209	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GAPDH—osteoporosis	7.9e-05	0.00205	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	7.86e-05	0.00204	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CALCR—osteoporosis	7.84e-05	0.00204	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PTH1R—osteoporosis	7.84e-05	0.00204	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CA2—osteoporosis	7.83e-05	0.00203	CbGpPWpGaD
Sulpiride—CA9—Metabolism—OXCT1—osteoporosis	7.83e-05	0.00203	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—CNR2—osteoporosis	7.82e-05	0.00203	CbGpPWpGaD
Sulpiride—CA2—Metabolism—IDH2—osteoporosis	7.69e-05	0.002	CbGpPWpGaD
Sulpiride—CA12—Metabolism—RAP1A—osteoporosis	7.69e-05	0.002	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.67e-05	0.00199	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MGLL—osteoporosis	7.63e-05	0.00198	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	7.59e-05	0.00197	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—RPL24—osteoporosis	7.43e-05	0.00193	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—WNT1—osteoporosis	7.35e-05	0.00191	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP27A1—osteoporosis	7.23e-05	0.00188	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ENO1—osteoporosis	7.19e-05	0.00187	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PSMA2—osteoporosis	7.08e-05	0.00184	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PSMA5—osteoporosis	7.08e-05	0.00184	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ACP5—osteoporosis	7.04e-05	0.00183	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—ADCY5—osteoporosis	6.88e-05	0.00179	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—MGLL—osteoporosis	6.86e-05	0.00178	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—LEP—osteoporosis	6.67e-05	0.00173	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—PTHLH—osteoporosis	6.65e-05	0.00173	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PTH1R—osteoporosis	6.6e-05	0.00172	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CALCR—osteoporosis	6.6e-05	0.00172	CbGpPWpGaD
Sulpiride—CA2—Metabolism—TPI1—osteoporosis	6.54e-05	0.0017	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—TLN1—osteoporosis	6.53e-05	0.0017	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.52e-05	0.00169	CbGpPWpGaD
Sulpiride—CA9—Metabolism—IDH2—osteoporosis	6.48e-05	0.00169	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—REN—osteoporosis	6.28e-05	0.00163	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—MGLL—osteoporosis	6.23e-05	0.00162	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ENO1—osteoporosis	6.22e-05	0.00162	CbGpPWpGaD
Sulpiride—CA2—Metabolism—P4HB—osteoporosis	6.15e-05	0.0016	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—PTH—osteoporosis	6.14e-05	0.0016	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PSMA2—osteoporosis	6.13e-05	0.00159	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PSMA5—osteoporosis	6.13e-05	0.00159	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP27A1—osteoporosis	6.1e-05	0.00159	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GAPDH—osteoporosis	6.04e-05	0.00157	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CALCR—osteoporosis	6e-05	0.00156	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PTH1R—osteoporosis	6e-05	0.00156	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CNR2—osteoporosis	5.98e-05	0.00156	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—FDPS—osteoporosis	5.94e-05	0.00155	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PKM—osteoporosis	5.94e-05	0.00155	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ACP5—osteoporosis	5.93e-05	0.00154	CbGpPWpGaD
Sulpiride—CA2—Metabolism—RAP1A—osteoporosis	5.88e-05	0.00153	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—CALCA—osteoporosis	5.85e-05	0.00152	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—ADCY5—osteoporosis	5.82e-05	0.00151	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CYP19A1—osteoporosis	5.75e-05	0.00149	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PGLS—osteoporosis	5.63e-05	0.00147	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GPD2—osteoporosis	5.63e-05	0.00147	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—WNT1—osteoporosis	5.63e-05	0.00146	CbGpPWpGaD
Sulpiride—CA9—Metabolism—TPI1—osteoporosis	5.51e-05	0.00143	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—ADCY5—osteoporosis	5.26e-05	0.00137	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—MGLL—osteoporosis	5.25e-05	0.00136	CbGpPWpGaD
Sulpiride—CA9—Metabolism—P4HB—osteoporosis	5.18e-05	0.00135	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PNP—osteoporosis	5.15e-05	0.00134	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ATIC—osteoporosis	5.15e-05	0.00134	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SOST—osteoporosis	5.12e-05	0.00133	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—LEP—osteoporosis	5.11e-05	0.00133	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GAPDH—osteoporosis	5.09e-05	0.00132	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—PTHLH—osteoporosis	5.09e-05	0.00132	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—POMC—osteoporosis	5.06e-05	0.00131	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYP19A1—osteoporosis	4.97e-05	0.00129	CbGpPWpGaD
Sulpiride—CA9—Metabolism—RAP1A—osteoporosis	4.96e-05	0.00129	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—MGLL—osteoporosis	4.76e-05	0.00124	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ENO1—osteoporosis	4.75e-05	0.00124	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ADCY5—osteoporosis	4.69e-05	0.00122	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PSMA2—osteoporosis	4.68e-05	0.00122	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PSMA5—osteoporosis	4.68e-05	0.00122	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GPX1—osteoporosis	4.68e-05	0.00122	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTH1R—osteoporosis	4.63e-05	0.0012	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CALCR—osteoporosis	4.63e-05	0.0012	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PTH—osteoporosis	4.53e-05	0.00118	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CALCA—osteoporosis	4.48e-05	0.00116	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CNR2—osteoporosis	4.42e-05	0.00115	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—OXCT1—osteoporosis	4.38e-05	0.00114	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CA2—osteoporosis	4.38e-05	0.00114	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MTHFR—osteoporosis	4.32e-05	0.00112	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MGLL—osteoporosis	4.27e-05	0.00111	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PTH—osteoporosis	4.12e-05	0.00107	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ADCY5—osteoporosis	4.06e-05	0.00106	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GPX1—osteoporosis	4.05e-05	0.00105	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.03e-05	0.00105	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.02e-05	0.00105	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CNR2—osteoporosis	4.01e-05	0.00104	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ENO1—osteoporosis	4.01e-05	0.00104	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PSMA2—osteoporosis	3.95e-05	0.00103	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PSMA5—osteoporosis	3.95e-05	0.00103	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—ACE—osteoporosis	3.92e-05	0.00102	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SOST—osteoporosis	3.92e-05	0.00102	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—POMC—osteoporosis	3.87e-05	0.00101	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP19A1—osteoporosis	3.8e-05	0.000988	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—WNT1—osteoporosis	3.77e-05	0.000981	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PTHLH—osteoporosis	3.76e-05	0.000977	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MTHFR—osteoporosis	3.73e-05	0.000971	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MGLL—osteoporosis	3.68e-05	0.000956	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—IDH2—osteoporosis	3.63e-05	0.000944	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LRP5—osteoporosis	3.59e-05	0.000933	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CALCR—osteoporosis	3.54e-05	0.000921	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTH1R—osteoporosis	3.54e-05	0.000921	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—IL6—osteoporosis	3.47e-05	0.000902	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PTH—osteoporosis	3.47e-05	0.000902	CbGpPWpGaD
Sulpiride—CA6—Metabolism—POMC—osteoporosis	3.45e-05	0.000898	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LRP6—osteoporosis	3.43e-05	0.000893	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP27A1—osteoporosis	3.41e-05	0.000888	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PTHLH—osteoporosis	3.41e-05	0.000887	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CNR2—osteoporosis	3.38e-05	0.000879	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ACP5—osteoporosis	3.32e-05	0.000863	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CALCA—osteoporosis	3.31e-05	0.00086	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.28e-05	0.000853	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP19A1—osteoporosis	3.2e-05	0.000833	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PTH—osteoporosis	3.15e-05	0.000819	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ADCY5—osteoporosis	3.1e-05	0.000807	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GPX1—osteoporosis	3.09e-05	0.000804	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TPI1—osteoporosis	3.09e-05	0.000803	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.08e-05	0.0008	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CNR2—osteoporosis	3.07e-05	0.000798	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—POMC—osteoporosis	3.06e-05	0.000796	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CALCA—osteoporosis	3e-05	0.000781	CbGpPWpGaD
Sulpiride—CA12—Metabolism—POMC—osteoporosis	2.99e-05	0.000777	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—P4HB—osteoporosis	2.9e-05	0.000755	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TLN1—osteoporosis	2.9e-05	0.000754	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—WNT1—osteoporosis	2.89e-05	0.000751	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PTHLH—osteoporosis	2.87e-05	0.000747	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MTHFR—osteoporosis	2.86e-05	0.000742	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GAPDH—osteoporosis	2.85e-05	0.000741	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MGLL—osteoporosis	2.81e-05	0.000732	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—RAP1A—osteoporosis	2.78e-05	0.000722	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LRP5—osteoporosis	2.75e-05	0.000714	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LRP6—osteoporosis	2.63e-05	0.000683	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ADCY5—osteoporosis	2.62e-05	0.00068	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PTHLH—osteoporosis	2.61e-05	0.000679	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GPX1—osteoporosis	2.61e-05	0.000678	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CALCA—osteoporosis	2.53e-05	0.000658	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—P4HB—osteoporosis	2.5e-05	0.00065	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—IL6—osteoporosis	2.49e-05	0.000648	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—LEP—osteoporosis	2.43e-05	0.000633	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTH—osteoporosis	2.43e-05	0.000632	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.42e-05	0.000629	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MTHFR—osteoporosis	2.41e-05	0.000626	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RAP1A—osteoporosis	2.39e-05	0.000621	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CNR2—osteoporosis	2.37e-05	0.000616	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADCY5—osteoporosis	2.35e-05	0.000612	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—POMC—osteoporosis	2.34e-05	0.000609	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NFATC1—osteoporosis	2.33e-05	0.000606	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DKK1—osteoporosis	2.31e-05	0.000602	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CALCA—osteoporosis	2.3e-05	0.000598	CbGpPWpGaD
Sulpiride—CA2—Metabolism—POMC—osteoporosis	2.28e-05	0.000594	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ENO1—osteoporosis	2.24e-05	0.000583	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—WNT1—osteoporosis	2.23e-05	0.000579	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TLN1—osteoporosis	2.22e-05	0.000577	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PSMA2—osteoporosis	2.21e-05	0.000575	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PSMA5—osteoporosis	2.21e-05	0.000575	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGA—osteoporosis	2.17e-05	0.000564	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADCY5—osteoporosis	2.14e-05	0.000555	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—POMC—osteoporosis	2.09e-05	0.000544	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTHLH—osteoporosis	2.02e-05	0.000524	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—BMP2—osteoporosis	2.02e-05	0.000524	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—IGF1—osteoporosis	2.01e-05	0.000523	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGB—osteoporosis	1.97e-05	0.000513	CbGpPWpGaD
Sulpiride—CA9—Metabolism—POMC—osteoporosis	1.92e-05	0.0005	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—P4HB—osteoporosis	1.91e-05	0.000497	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—IL6—osteoporosis	1.91e-05	0.000495	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PSMA2—osteoporosis	1.9e-05	0.000495	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PSMA5—osteoporosis	1.9e-05	0.000495	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTH—osteoporosis	1.86e-05	0.000484	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RAP1A—osteoporosis	1.83e-05	0.000476	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CNR2—osteoporosis	1.81e-05	0.000472	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	1.8e-05	0.000468	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP19A1—osteoporosis	1.79e-05	0.000466	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NFATC1—osteoporosis	1.78e-05	0.000464	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CALCA—osteoporosis	1.77e-05	0.000461	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DKK1—osteoporosis	1.77e-05	0.00046	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—POMC—osteoporosis	1.73e-05	0.00045	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—WNT1—osteoporosis	1.71e-05	0.000443	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGA—osteoporosis	1.66e-05	0.000431	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADCY5—osteoporosis	1.63e-05	0.000425	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—KL—osteoporosis	1.61e-05	0.000419	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—POMC—osteoporosis	1.57e-05	0.000409	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTHLH—osteoporosis	1.54e-05	0.000401	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—BMP2—osteoporosis	1.54e-05	0.000401	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL6R—osteoporosis	1.53e-05	0.000399	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGB—osteoporosis	1.51e-05	0.000392	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ADCY5—osteoporosis	1.47e-05	0.000381	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GPX1—osteoporosis	1.46e-05	0.00038	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PSMA5—osteoporosis	1.46e-05	0.000379	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PSMA2—osteoporosis	1.46e-05	0.000379	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CALCA—osteoporosis	1.36e-05	0.000353	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MTHFR—osteoporosis	1.35e-05	0.00035	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—POMC—osteoporosis	1.32e-05	0.000344	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADCY5—osteoporosis	1.26e-05	0.000328	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—KL—osteoporosis	1.23e-05	0.000321	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SPP1—osteoporosis	1.22e-05	0.000317	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—POMC—osteoporosis	1.2e-05	0.000313	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.17e-05	0.000305	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IRS2—osteoporosis	1.1e-05	0.000287	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LEP—osteoporosis	1.08e-05	0.000281	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—POMC—osteoporosis	1.08e-05	0.00028	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ESR1—osteoporosis	1.03e-05	0.000268	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADCY5—osteoporosis	9.66e-06	0.000251	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IRS1—osteoporosis	9.64e-06	0.000251	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SPP1—osteoporosis	9.34e-06	0.000243	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—POMC—osteoporosis	9.28e-06	0.000241	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL6R—osteoporosis	9.06e-06	0.000235	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1—osteoporosis	8.93e-06	0.000232	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IRS2—osteoporosis	8.45e-06	0.00022	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LEP—osteoporosis	8.27e-06	0.000215	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ESR1—osteoporosis	7.89e-06	0.000205	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IRS1—osteoporosis	7.38e-06	0.000192	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—POMC—osteoporosis	7.1e-06	0.000185	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL6R—osteoporosis	6.93e-06	0.00018	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1—osteoporosis	6.83e-06	0.000178	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL6—osteoporosis	6.83e-06	0.000178	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MYC—osteoporosis	5.37e-06	0.00014	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TGFB1—osteoporosis	5.35e-06	0.000139	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL6—osteoporosis	5.23e-06	0.000136	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MYC—osteoporosis	4.11e-06	0.000107	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.1e-06	0.000107	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL6—osteoporosis	4.03e-06	0.000105	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL6—osteoporosis	3.09e-06	8.03e-05	CbGpPWpGaD
